Clinical Trial

Lebanese Interhospital Pneumococcal Surveillance Program

Study acronym: LIPSP
Recruiting
View on ClinicalTrials.gov →
Summary
Streptococcus pneumoniae (pneumococcus) is a bacterium that causes severe infections in children and adults such as meningitis, pneumonia, and blood stream infection. There are many types of these bacteria defined by the type of sugar coat that they have. These are classified as serotypes. There are common serotypes that cause severe disease and are preventable by vaccination of children. Other less common types are more difficult to prevent. The investigators aim to determine the serotypes that cause invasive pneumococcal disease in Lebanon and to study their sensitivity to different antibiotics. The investigators will collect bacterial isolates from different hospitals in Lebanon isolated from the blood or spinal fluid of patients with invasive pneumococcal disease. This information will help the investigators determine the usefulness of available pneumococcal vaccines in preventing these infections. The data will be distributed to all primary care physicians treating children in Lebanon and will be shared with the Ministry of Health.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2009-05-13; most recent amendment 2023-02-02.
Trial Details
NCT Number NCT00901602
Lead Sponsor American University of Beirut Medical Center
Collaborators: PneumoADIP, Pfizer
Conditions Pneumonia, Meningitis, Sepsis, Bacteremia
Enrollment 700 participants
Start Date 2005-10
Primary Completion 2030-10 (estimated)
Study Completion 2030-10 (estimated)
Updated on ClinicalTrials.gov 2023-02-03